Last reviewed · How we verify
Dexmedetomidine-Dexamethasone
This combination drug pairs dexmedetomidine (an alpha-2 adrenergic agonist) with dexamethasone (a corticosteroid) to provide sedation and anti-inflammatory effects.
This combination drug pairs dexmedetomidine (an alpha-2 adrenergic agonist) with dexamethasone (a corticosteroid) to provide sedation and anti-inflammatory effects. Used for Sedation and analgesia in perioperative or intensive care settings, Reduction of postoperative inflammation and pain.
At a glance
| Generic name | Dexmedetomidine-Dexamethasone |
|---|---|
| Sponsor | University of Chile |
| Drug class | Alpha-2 adrenergic agonist / Corticosteroid combination |
| Target | Alpha-2 adrenergic receptor; Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Anesthesia / Critical Care / Perioperative Medicine |
| Phase | FDA-approved |
Mechanism of action
Dexmedetomidine acts as a selective alpha-2 adrenergic agonist that produces sedation, analgesia, and anxiolysis by activating presynaptic alpha-2 receptors in the central nervous system. Dexamethasone is a potent glucocorticoid that suppresses inflammation and immune responses. The combination leverages both sedative-analgesic and anti-inflammatory properties for perioperative or critical care use.
Approved indications
- Sedation and analgesia in perioperative or intensive care settings
- Reduction of postoperative inflammation and pain
Common side effects
- Hypotension
- Bradycardia
- Dry mouth
- Hyperglycemia
- Rebound hypertension
Key clinical trials
- Comparison Between Dexamethasone and Dexmedetomidine in Spinal Anesthesia for Cases With Fracture Pelvis Fixation (EARLY_PHASE1)
- PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults (NA)
- Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults (NA)
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Comparison of Dexmedetomidine and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy (PHASE3)
- Effect of Dexmedetomidine Versus Dexamethasone as Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Plane Block on Postoperative Analgesia in Myasthenic Patients Undergoing Thoracoscopic Thymectomy (NA)
- Dexmedetomidine and Dexamethasone Added as Adjuvant Infraclavicular Brachial Plexus Block in Upper Limb Surgery
- Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine-Dexamethasone CI brief — competitive landscape report
- Dexmedetomidine-Dexamethasone updates RSS · CI watch RSS
- University of Chile portfolio CI